Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis

Gaetano Cairo, Stefania Recalcati, Giuliana Montosi, Elisa Castrusini, Dario Conte, Antonello Pietrangelo

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

In genetic hemochromatosis (GH), excess iron is deposited in parenchyma) cells, whereas little iron is found in reticuloendothelial (RE) cells until the later stages of the disease. As iron absorption is inversely related to RE cells stores, a failure of RE to retain iron has been proposed as the basic defect in GH. In RE cells of GH subjects, we examined the activity of iron regulatory protein (IRP), a reliable indicator of the elusive regulatory labile iron pool, which modulates cellular iron homeostasis through control of ferritin (Ft) and transferrin receptor gene expression. RNA-bandshift essays showed a significant increase in IRP activity in monocytes from 16 patients with untreated GH compared with 28 control subjects (1.5-fold) and five patients with secondary hemochromatosis (SH) with similar iron burden (fourfold). In 17 phlebotomy-treated GH patients, IRP activity did not differ from that of control subjects. In both GH and SH monocyte-macrophages, Ft content increased by twofold and the L subunit-rich isoferritin profile was unchanged as compared with controls. IRP activity was still upregulated in vitro in monocyte-derived macrophages of GH subjects but, following manipulations of iron levels, was modulated normally. Therefore, the sustained activity of monocyte IRP found in vivo in monocytes of GH patients is not due to an inherent defect of its control, but is rather the expression of a critical abnormality of iron metabolism, eg, a paradoxical contraction of the regulatory iron pool. By preventing Ft mRNA translation, high IRP activity in monocytes may represent a molecular mechanism contributing to the inadequate Ft accumulation and insufficient RE iron storage in GH.

Original languageEnglish
Pages (from-to)2546-2553
Number of pages8
JournalBlood
Volume89
Issue number7
Publication statusPublished - Apr 1 1997

Fingerprint

Iron-Regulatory Proteins
Hemochromatosis
Monocytes
Iron
Ferritins
Macrophages
Defects
Transferrin Receptors
Phlebotomy
Protein Biosynthesis
Metabolism
Gene expression

ASJC Scopus subject areas

  • Hematology

Cite this

Cairo, G., Recalcati, S., Montosi, G., Castrusini, E., Conte, D., & Pietrangelo, A. (1997). Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood, 89(7), 2546-2553.

Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. / Cairo, Gaetano; Recalcati, Stefania; Montosi, Giuliana; Castrusini, Elisa; Conte, Dario; Pietrangelo, Antonello.

In: Blood, Vol. 89, No. 7, 01.04.1997, p. 2546-2553.

Research output: Contribution to journalArticle

Cairo, G, Recalcati, S, Montosi, G, Castrusini, E, Conte, D & Pietrangelo, A 1997, 'Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis', Blood, vol. 89, no. 7, pp. 2546-2553.
Cairo G, Recalcati S, Montosi G, Castrusini E, Conte D, Pietrangelo A. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood. 1997 Apr 1;89(7):2546-2553.
Cairo, Gaetano ; Recalcati, Stefania ; Montosi, Giuliana ; Castrusini, Elisa ; Conte, Dario ; Pietrangelo, Antonello. / Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. In: Blood. 1997 ; Vol. 89, No. 7. pp. 2546-2553.
@article{2bffa80fcd18448bb2fdf11661983374,
title = "Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis",
abstract = "In genetic hemochromatosis (GH), excess iron is deposited in parenchyma) cells, whereas little iron is found in reticuloendothelial (RE) cells until the later stages of the disease. As iron absorption is inversely related to RE cells stores, a failure of RE to retain iron has been proposed as the basic defect in GH. In RE cells of GH subjects, we examined the activity of iron regulatory protein (IRP), a reliable indicator of the elusive regulatory labile iron pool, which modulates cellular iron homeostasis through control of ferritin (Ft) and transferrin receptor gene expression. RNA-bandshift essays showed a significant increase in IRP activity in monocytes from 16 patients with untreated GH compared with 28 control subjects (1.5-fold) and five patients with secondary hemochromatosis (SH) with similar iron burden (fourfold). In 17 phlebotomy-treated GH patients, IRP activity did not differ from that of control subjects. In both GH and SH monocyte-macrophages, Ft content increased by twofold and the L subunit-rich isoferritin profile was unchanged as compared with controls. IRP activity was still upregulated in vitro in monocyte-derived macrophages of GH subjects but, following manipulations of iron levels, was modulated normally. Therefore, the sustained activity of monocyte IRP found in vivo in monocytes of GH patients is not due to an inherent defect of its control, but is rather the expression of a critical abnormality of iron metabolism, eg, a paradoxical contraction of the regulatory iron pool. By preventing Ft mRNA translation, high IRP activity in monocytes may represent a molecular mechanism contributing to the inadequate Ft accumulation and insufficient RE iron storage in GH.",
author = "Gaetano Cairo and Stefania Recalcati and Giuliana Montosi and Elisa Castrusini and Dario Conte and Antonello Pietrangelo",
year = "1997",
month = "4",
day = "1",
language = "English",
volume = "89",
pages = "2546--2553",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "7",

}

TY - JOUR

T1 - Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis

AU - Cairo, Gaetano

AU - Recalcati, Stefania

AU - Montosi, Giuliana

AU - Castrusini, Elisa

AU - Conte, Dario

AU - Pietrangelo, Antonello

PY - 1997/4/1

Y1 - 1997/4/1

N2 - In genetic hemochromatosis (GH), excess iron is deposited in parenchyma) cells, whereas little iron is found in reticuloendothelial (RE) cells until the later stages of the disease. As iron absorption is inversely related to RE cells stores, a failure of RE to retain iron has been proposed as the basic defect in GH. In RE cells of GH subjects, we examined the activity of iron regulatory protein (IRP), a reliable indicator of the elusive regulatory labile iron pool, which modulates cellular iron homeostasis through control of ferritin (Ft) and transferrin receptor gene expression. RNA-bandshift essays showed a significant increase in IRP activity in monocytes from 16 patients with untreated GH compared with 28 control subjects (1.5-fold) and five patients with secondary hemochromatosis (SH) with similar iron burden (fourfold). In 17 phlebotomy-treated GH patients, IRP activity did not differ from that of control subjects. In both GH and SH monocyte-macrophages, Ft content increased by twofold and the L subunit-rich isoferritin profile was unchanged as compared with controls. IRP activity was still upregulated in vitro in monocyte-derived macrophages of GH subjects but, following manipulations of iron levels, was modulated normally. Therefore, the sustained activity of monocyte IRP found in vivo in monocytes of GH patients is not due to an inherent defect of its control, but is rather the expression of a critical abnormality of iron metabolism, eg, a paradoxical contraction of the regulatory iron pool. By preventing Ft mRNA translation, high IRP activity in monocytes may represent a molecular mechanism contributing to the inadequate Ft accumulation and insufficient RE iron storage in GH.

AB - In genetic hemochromatosis (GH), excess iron is deposited in parenchyma) cells, whereas little iron is found in reticuloendothelial (RE) cells until the later stages of the disease. As iron absorption is inversely related to RE cells stores, a failure of RE to retain iron has been proposed as the basic defect in GH. In RE cells of GH subjects, we examined the activity of iron regulatory protein (IRP), a reliable indicator of the elusive regulatory labile iron pool, which modulates cellular iron homeostasis through control of ferritin (Ft) and transferrin receptor gene expression. RNA-bandshift essays showed a significant increase in IRP activity in monocytes from 16 patients with untreated GH compared with 28 control subjects (1.5-fold) and five patients with secondary hemochromatosis (SH) with similar iron burden (fourfold). In 17 phlebotomy-treated GH patients, IRP activity did not differ from that of control subjects. In both GH and SH monocyte-macrophages, Ft content increased by twofold and the L subunit-rich isoferritin profile was unchanged as compared with controls. IRP activity was still upregulated in vitro in monocyte-derived macrophages of GH subjects but, following manipulations of iron levels, was modulated normally. Therefore, the sustained activity of monocyte IRP found in vivo in monocytes of GH patients is not due to an inherent defect of its control, but is rather the expression of a critical abnormality of iron metabolism, eg, a paradoxical contraction of the regulatory iron pool. By preventing Ft mRNA translation, high IRP activity in monocytes may represent a molecular mechanism contributing to the inadequate Ft accumulation and insufficient RE iron storage in GH.

UR - http://www.scopus.com/inward/record.url?scp=0030894809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030894809&partnerID=8YFLogxK

M3 - Article

C2 - 9116301

AN - SCOPUS:0030894809

VL - 89

SP - 2546

EP - 2553

JO - Blood

JF - Blood

SN - 0006-4971

IS - 7

ER -